Cerus Corp Sustainability Reports
Cerus Corporation is a biomedical products company focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The company provides pathogen-reduction systems for platelets, plasma, and red blood cells to blood centers and hospitals globally.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 254900BIEY9XIDA04Q21
FIGI: BBG001S97DG4
13 reports from 2014 to 2025
